General

Sort by Latest
Italy: Pharmaceutical company fined by the Italian Competition Authority for the sale of a lifesaving drug at excessive prices
Essetifin S.p.A., Leadiant Biosciences Ltd., Leadiant GmbH and Sigma – Tau Arzenmittel GmbH (“Leadiant”) were recently sanctioned by the Italian Competition Authority (“ICA”) after investigations revealed an abuse of dominant position in the national market of the sale and production of a pharmaceutical product made of chenodeoxycholic acid (“CDCA”). CDCA is an active ingredient widely used to cure cerebrotendinous xanthomatosis (“CTX”), an ultra-rare disease. According to the ICA,...
July 18, 2022
6 min read
Spanish Competition Authority analyses distribution...
On June 22, 2022, the Spanish Competition Authority (“CNMC”)...
July 18, 2022
6 min read
Final(ly) Rules of Procedure of the UPC
Apart from the Unified Patent Court Agreement and a large...
July 18, 2022
1 min read
To opt-out or not? The UPC will change the rules of...
Early this year it became clear that the long-pending reform...
June 1, 2022
7 min read
Artificial Intelligence Systems for Medical Diagnosis
The Italian Ministry of Health has published a document on its website entitled “Artificial Intelligence...
May 25, 2022
1 min read
China Health and Medical Data Protection (I): Human Genetic Resources Information
I. An Overview of Regulatory Regime Under the Chinese law, human generic resources...
May 24, 2022
13 min read
The European Health Data Space Proposal of the European Commission
Unleashing the full potential of health data through facilitating secondary use? On...
May 5, 2022
12 min read
The UPC Committees rule!
Start of the Provisional Application Phase and first committee meetings The Provisional...
April 7, 2022
12 min read
Gender Equality in the COVID-Impacted Workplace: A Global View, Bird & Bird & Sheppard Mullin Women in Healthcare Leadership Collaborative
Bird & Bird hosted a virtual event to discuss gender equality in the Covid-impacted workplace with...
April 1, 2022
1 min read
The Return of Biosimilar Substitution in France
Every year the Social Security Financing Law for 2022 (LFSS 2022) introduces several measures resulting...
March 28, 2022
3 min read
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.